Literature DB >> 32553634

Factors associated with insurance coverage of tofacitinib for alopecia areata: A retrospective review from an academic institution.

Hannah J Thompson1, Theresa Vavra2, Ali Jabbari3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32553634      PMCID： PMC7572551          DOI： 10.1016/j.jaad.2020.06.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Treatment of Alopecia Areata With Tofacitinib.

Authors:  Omer Ibrahim; Cheryl B Bayart; Sara Hogan; Melissa Piliang; Wilma F Bergfeld
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

Review 2.  JAK inhibitors in dermatology: The promise of a new drug class.

Authors:  William Damsky; Brett A King
Journal:  J Am Acad Dermatol       Date:  2017-01-28       Impact factor: 11.527

3.  Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

Authors:  Milène Kennedy Crispin; Justin M Ko; Brittany G Craiglow; Shufeng Li; Gautam Shankar; Jennifer R Urban; James C Chen; Jane E Cerise; Ali Jabbari; Mårten Cg Winge; M Peter Marinkovich; Angela M Christiano; Anthony E Oro; Brett A King
Journal:  JCI Insight       Date:  2016-09-22

4.  An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.

Authors:  A Jabbari; F Sansaricq; J Cerise; J C Chen; A Bitterman; G Ulerio; J Borbon; R Clynes; A M Christiano; J Mackay-Wiggan
Journal:  J Invest Dermatol       Date:  2018-02-13       Impact factor: 8.551

5.  Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.

Authors:  Ali Jabbari; Zhenpeng Dai; Luzhou Xing; Jane E Cerise; Yuval Ramot; Yackov Berkun; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky; Angela M Christiano; Raphael Clynes; Abraham Zlotogorski
Journal:  EBioMedicine       Date:  2015-02-26       Impact factor: 8.143
  5 in total
  1 in total

Review 1.  An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.

Authors:  Maddison Lensing; Ali Jabbari
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.